As political pressure on the pharmaceutical industry builds, Merck has become the latest big drug maker to commit to halting price hikes.
In a brief statement, the company agreed not to increase the average net prices of its medicines by more than inflation annually, and then also dropped the wholesale — or list — price by 60 percent on its Zepatier hepatitis C treatment and lowered list prices by 10 percent on a half dozen other drugs. However, the extent to which its moves will actually be meaningful are being questioned.
About the Author Reprints
This is / was news to me – “And Gilead Sciences, Roche, and Novo Nordisk have begun to rescind some price hikes.” I wonder if I am alone, or if Mr. Ed was ‘making news’ very subtly.
https://www.bloomberg.com/news/articles/2018-07-10/drugmakers-cancel-price-hikes-as-california-law-takes-effect